Also trades as: 1548.HK (HKSE) · $vol 194M
GNNSF OTC
Genscript Biotech Corporation
1W: +9.3%
1M: +18.7%
3M: +245.0%
YTD: +200.0%
1Y: +145.3%
3Y: +160.4%
5Y: +174.6%
$5.52
-0.18 (-3.16%)
Weekly Expected Move ±14.5%
$4
$5
$6
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$4.9B
-8.1% ▼
5Y CAGR: +27.4%
Total Liabilities
$876M
-8.2% ▼
5Y CAGR: +6.8%
Shareholders Equity
$4.0B
-8.4% ▼
5Y CAGR: +34.4%
Cash & Investments
$843M
+35.7% ▲
5Y CAGR: +1.8%
Total Debt
$523M
+206.7% ▲
5Y CAGR: +56.9%
Net Debt
$350M
+806.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.2B | $1.0B | $1.4B | $132M | $174M |
| Short-Term Investments | $222M | $439M | $482M | $489M | $669M |
| Cash & ST Investments | $1.4B | $1.5B | $1.9B | $621M | $843M |
| Net Receivables | $169M | $172M | $300M | $119M | $134M |
| Inventory | $44M | $60M | $53M | $31M | $40M |
| Other Current Assets | $16M | $42M | $70M | $55M | $40M |
| Total Current Assets | $1.6B | $1.8B | $2.4B | $835M | $1.1B |
| Property, Plant & Equip. | $492M | $647M | $751M | $603M | $623M |
| Goodwill & Intangibles | $66M | $26M | $20M | $14M | $15M |
| Long-Term Investments | -$204M | -$423M | $91M | $3.3B | $3.1B |
| Other Non-Current Assets | $235M | $516M | $156M | $498M | $27M |
| Total Non-Current Assets | $595M | $781M | $1.0B | $4.4B | $3.8B |
| Total Assets | $2.2B | $2.5B | $3.4B | $5.3B | $4.9B |
| — Liabilities — | |||||
| Accounts Payable | $30M | $56M | $40M | $30M | $37M |
| Short-Term Debt | $521K | $34M | $57M | $89M | $468M |
| Deferred Revenue | $35M | $42M | $92M | $0 | $48M |
| Other Current Liabilities | $235M | $194M | $132M | $172M | $83M |
| Total Current Liabilities | $464M | $546M | $495M | $307M | $720M |
| Long-Term Debt | $121M | $261M | $287M | $17M | $0 |
| Other Non-Current Liab. | $261M | $307M | $443M | $567M | $87M |
| Total Non-Current Liabilities | $433M | $638M | $848M | $648M | $156M |
| Total Liabilities | $1.1B | $1.2B | $1.3B | $955M | $876M |
| — Equity — | |||||
| Common Stock | $2M | $2M | $2M | $2M | $2M |
| Retained Earnings | -$558M | -$502M | -$632M | $2.4B | $0 |
| Accumulated OCI | $61M | $50M | $57M | -$21M | $0 |
| Total Stockholders Equity | $1.0B | $1.0B | $1.4B | $4.3B | $4.0B |
| Total Liabilities & Equity | $2.2B | $2.5B | $3.4B | $5.3B | $4.9B |
| — Key Metrics — | |||||
| Total Debt | $156M | $350M | $417M | $171M | $523M |
| Net Debt | -$1.0B | -$674M | -$1.0B | $39M | $350M |
| Total Investments | $18M | $16M | $573M | $3.8B | $3.8B |